Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02050321
What this trial is testing

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
University of Arizona 2
Early research (Phase 1)Looking for participantsNCT07203391
What this trial is testing

Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Who this might be right for
Uveal Melanoma, Metastatic
St Vincent's Hospital, Sydney 8
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Not applicableLooking for participantsNCT06680323
What this trial is testing

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

Who this might be right for
MelanomaSpitzoid MelanomaCongenital Nevi
University Hospital Tuebingen 200
Testing effectiveness (Phase 2)UnknownNCT00004025
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company 36
Not applicableUnknownNCT04353050
What this trial is testing

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Who this might be right for
MelanomaMelanoma (Skin)Moles+9 more
Russian Academy of Medical Sciences 350
Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing

APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma

Who this might be right for
Melanoma
Aprea Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT00289627
What this trial is testing

A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 155
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT03922880
What this trial is testing

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Testing effectiveness (Phase 2)Study completedNCT00109863
What this trial is testing

Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 14
Early research (Phase 1)Active Not RecruitingNCT05640193
What this trial is testing

LN-144 in People With Metastatic Melanoma to the Brain

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Not applicableStudy completedNCT05714371
What this trial is testing

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 618
Not applicableStudy completedNCT01432860
What this trial is testing

A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination

Who this might be right for
Melanoma
Northwestern University 1,000
Early research (Phase 1)UnknownNCT01946373
What this trial is testing

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Who this might be right for
Melanoma
Karolinska University Hospital 20
Next Page